Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin Versus Doxorubicine in Patients With Leiomyosarcoma
Clinical trial NCT02997358 · COMPLETED
Trial details
- NCT number
- NCT02997358
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-18
- Primary completion
- 2021-07-28
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.